LOINC_NUM
stringlengths
3
8
COMPONENT
stringlengths
2
246
PROPERTY
stringlengths
1
29
TIME_ASPCT
stringlengths
1
15
SYSTEM
stringlengths
1
106
SCALE_TYP
stringclasses
10 values
METHOD_TYP
stringlengths
1
57
CLASS
stringlengths
2
24
CLASSTYPE
int64
1
4
LONG_COMMON_NAME
stringlengths
3
254
SHORTNAME
stringlengths
2
51
EXTERNAL_COPYRIGHT_NOTICE
stringlengths
39
2.6k
STATUS
stringclasses
4 values
VersionFirstReleased
stringlengths
1
7
VersionLastChanged
stringlengths
1
5
96084-9
HEDIS Measurement Year 2020 Value Set - Quantitative Urine Albumin Lab Test
-
Pt
^Patient
-
null
PANEL.HEDIS
1
HEDIS MY 2020 Value Set - Quantitative Urine Albumin Lab Test
HEDIS MY 2020 Qn Ur Alb Lab Test
null
DISCOURAGED
2.69
2.72
96085-6
HEDIS Measurement Year 2020 Value Set - Urine Albumin Creatinine Ratio Lab Test
-
Pt
^Patient
-
null
PANEL.HEDIS
1
HEDIS MY 2020 Value Set - Urine Albumin Creatinine Ratio Lab Test
HEDIS MY 2020 Ur Alb Creat Rto Lab Test
null
DISCOURAGED
2.69
2.72
96086-4
HEDIS Measurement Year 2020 Value Set - Urine Creatinine Lab Test
-
Pt
^Patient
-
null
PANEL.HEDIS
1
HEDIS MY 2020 Value Set - Urine Creatinine Lab Test
HEDIS MY 2020 Ur Creat Lab Test
null
DISCOURAGED
2.69
2.72
96087-2
Standard thickness parameter
Len
Pt
Cornea.right
Qn
Tonometry
EYE.TONOMETRY
2
Right cornea Standard thickness parameter
R cornea Standard thickness Tono
null
TRIAL
2.69
2.69
96088-0
Standard thickness parameter
Len
Pt
Cornea.left
Qn
Tonometry
EYE.TONOMETRY
2
Left cornea Standard thickness parameter
L cornea Standard thickness Tono
null
TRIAL
2.69
2.69
96089-8
Volume adjustment parameter
InvLen
Pt
Cornea.right
Qn
Tonometry
EYE.TONOMETRY
2
Right cornea Volume adjustment parameter
R cornea Vol Adj Tono
null
TRIAL
2.69
2.69
96090-6
Volume adjustment parameter
InvLen
Pt
Cornea.left
Qn
Tonometry
EYE.TONOMETRY
2
Left cornea Volume adjustment parameter
L cornea Vol Adj Tono
null
TRIAL
2.69
2.69
96091-4
SARS coronavirus 2 RdRp gene
PrThr
Pt
Saliva
Ord
Probe.amp.tar
MICRO
1
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
SARS-CoV-2 RdRp Sal Ql NAA+probe
null
ACTIVE
2.69
2.69
96092-2
Intraocular pressure^compensated
Pres
Pt
Eye.left
Qn
Calculated
EYE.TONOMETRY
2
Left eye Intraocular pressure--compensated Calculated
L eye IOP--comp Calc
null
TRIAL
2.69
2.69
96093-0
Intraocular pressure^compensated
Pres
Pt
Eye.right
Qn
Calculated
EYE.TONOMETRY
2
Right eye Intraocular pressure--compensated Calculated
R eye IOP--comp Calc
null
TRIAL
2.69
2.69
96094-8
SARS coronavirus 2 & SARS-related coronavirus RNA panel
-
Pt
Respiratory
-
Probe.amp.tar
PANEL.MICRO
1
SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
SARS-CoV-2+SARSr-CoV pnl Resp NAA+probe
null
ACTIVE
2.69
2.7
96095-5
Indicate the patient's primary medical condition category
Find
RptPeriod
^Patient
Nom
CMS Assessment
SURVEY.CMS
4
Indicate the patient's primary medical condition category during assessment period [CMS Assessment]
null
null
ACTIVE
2.69
2.69
96098-9
Wash upper body - functional goal
Find
Pt
^Patient
Ord
CMS Assessment
SURVEY.CMS
4
Wash upper body - functional goal [CMS Assessment]
null
null
ACTIVE
2.69
2.69
9609-9
Hepatitis C virus 22-3 Ab
PrThr
Pt
Ser
Ord
IB
MICRO
1
Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot
HCV22-3 Ab Ser Ql IB
null
ACTIVE
1.0i
2.73
96099-7
LCDS v5.00 - Mobility - admission performance
-
RptPeriod
^Patient
-
CMS Assessment
PANEL.SURVEY.CMS
4
LCDS v5.00 - Mobility - admission performance during assessment period [CMS Assessment]
null
null
ACTIVE
2.69
2.69
96100-3
LCDS v5.00 - Mobility - discharge performance
-
RptPeriod
^Patient
-
CMS Assessment
PANEL.SURVEY.CMS
4
LCDS v5.00 - Mobility - discharge performance during assessment period [CMS Assessment]
null
null
ACTIVE
2.69
2.69
96101-1
Tobacco use frequency
NRat
Pt
^Patient
Ord
null
H&P.HX
2
Tobacco use frequency
Tobacco use freq
null
ACTIVE
2.69
2.69
96102-9
Age when stopped substance abuse
Time
Pt
^Patient
Qn
null
H&P.HX
2
Age when stopped substance abuse
Age when stopped substance abuse
null
ACTIVE
2.69
2.69
96103-7
Tobacco amount per D
NRat
Pt
^Patient
Qn
null
H&P.HX
2
Tobacco amount per day
Tobacco amount per D nRate
null
ACTIVE
2.69
2.69
96104-5
Wound stage
Find
Pt
Foot
Ord
UT-DWCS
CLIN
2
Wound stage Foot University of Texas diabetic wound classification system
Wound stage Ft UT-DWCS
null
ACTIVE
2.69
2.69
96105-2
Wound grade
Find
Pt
Foot
Ord
UT-DWCS
CLIN
2
Wound grade Foot University of Texas diabetic wound classification system
Wound grade Ft UT-DWCS
null
ACTIVE
2.69
2.69
96106-0
University of Texas diabetic wound classification system panel
-
Pt
Foot
-
UT-DWCS
PANEL.CLIN
2
University of Texas diabetic wound classification system panel Foot University of Texas diabetic wound classification system
UT-DWCS pnl Ft UT-DWCS
null
ACTIVE
2.69
2.69
9610-7
Hepatitis C virus c33c Ab
PrThr
Pt
Ser
Ord
IB
MICRO
1
Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot
HCV C33c Ab Ser Ql IB
null
ACTIVE
1.0i
2.73
96107-8
Bedaquiline
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Bedaquiline [Susceptibility] by Genotype method
Bedaquiline Islt Genotyp
null
ACTIVE
2.69
2.69
96108-6
Clofazimine
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Clofazimine [Susceptibility] by Genotype method
Clofazamine Islt Genotyp
null
ACTIVE
2.69
2.69
96109-4
Delamanid
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Delamanid [Susceptibility] by Genotype method
Delamanid Islt Genotyp
null
ACTIVE
2.69
2.69
96110-2
Ethionamide
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Ethionamide [Susceptibility] by Genotype method
Ethionamide Islt Genotyp
null
ACTIVE
2.69
2.69
96111-0
Linezolid
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Linezolid [Susceptibility] by Genotype method
Linezolid Islt Genotyp
null
ACTIVE
2.69
2.69
96112-8
Moxifloxacin
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Moxifloxacin [Susceptibility] by Genotype method
Moxifloxacin Islt Genotyp
null
ACTIVE
2.69
2.69
96113-6
Rifabutin
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Rifabutin [Susceptibility] by Genotype method
Rifabutin Islt Genotyp
null
ACTIVE
2.69
2.69
96114-4
Streptomycin
Susc
Pt
Isolate
Ord
Genotyping
ABXBACT
1
Streptomycin [Susceptibility] by Genotype method
Streptomycin Islt Genotyp
null
ACTIVE
2.69
2.69
9611-5
Streptococcus pneumoniae Danish serotype 18C Ab.IgG
ACnc
Pt
Ser
Qn
IA
MICRO
1
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum by Immunoassay
S pneum Da 18C IgG Ser IA-aCnc
null
ACTIVE
1.0i
2.73
96115-1
Level of tumor invasion
Type
Pt
Colorectal cancer specimen
Nom
Haggitt
PATH.HISTO
1
Level of tumor invasion [Type] in Colorectal cancer specimen by Haggitt
Tumor invasion level CRC spec Haggitt
null
ACTIVE
2.69
2.69
96116-9
Anterior surgical resection
Type
Pt
Lower GI tract
Nom
null
PATH
1
Anterior surgical resection [Type] in Lower GI tract
Anterior surg resection Lower GI tract
null
ACTIVE
2.69
2.7
96117-7
Resection adequacy of non-malignant polyp
Find
Pt
Specimen
Ord
null
PATH
1
Resection adequacy of non-malignant polyp in Specimen Qualitative
Resection adeq non-malig polyp Spec Ql
null
ACTIVE
2.69
2.69
96118-5
SARS coronavirus 2 Ab panel
-
Pt
Bld.dot
-
IA
PANEL.MICRO
1
SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
SARS-CoV-2 Ab Pnl DBS IA
null
ACTIVE
2.69
2.69
96119-3
SARS coronavirus 2 Ag
PrThr
Pt
Respiratory.upper
Ord
IA
MICRO
1
SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
SARS-CoV-2 Ag Upper resp Ql IA
null
ACTIVE
2.69
2.69
96120-1
SARS coronavirus 2 RdRp gene
PrThr
Pt
Respiratory.lower
Ord
Probe.amp.tar
MICRO
1
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
SARS-CoV-2 RdRp Lower resp Ql NAA+probe
null
ACTIVE
2.69
2.69
96121-9
SARS-related coronavirus E gene
PrThr
Pt
Respiratory.lower
Ord
Probe.amp.tar
MICRO
1
SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
SARS-rel CoV E gene Low resp Ql NAA+prb
null
ACTIVE
2.69
2.69
96122-7
SARS-related coronavirus E gene
PrThr
Pt
Respiratory.upper
Ord
Probe.amp.tar
MICRO
1
SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
SARS-rel CoV E gene Upper resp Ql NAA+prb
null
ACTIVE
2.69
2.69
9612-3
Cortisol^15M post 250 ug corticotropin IM
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM
Cortis 15M p 250 ug ACTH IM SerPl-mCnc
null
ACTIVE
1.0i
2.73
96123-5
SARS coronavirus 2 RdRp gene
PrThr
Pt
Respiratory.upper
Ord
Probe.amp.tar
MICRO
1
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
SARS-CoV-2 RdRp Upper resp Ql NAA+probe
null
ACTIVE
2.69
2.69
96124-3
Long axis
Prctl
Pt
Femur.diaphysis^Fetus
Qn
Per estimated gestational age
OB.US
2
Fetal femur diaphysis length percentile per estimated gestational age
Fet FDL Prctl per est GA
null
ACTIVE
2.69
2.69
96125-0
Perimeter
Prctl
Pt
Abdomen^Fetus
Qn
Per estimated gestational age
OB.US
2
Fetal Abdomen Circumference Per estimated gestational age
Fet Abd Prctl Circum Per est GA
null
ACTIVE
2.69
2.69
96126-8
Evaluation note
Find
Pt
{Setting}
Doc
Recreational therapy
DOC.ONTOLOGY
2
Recreational therapy Evaluation note
Rec therapy Eval note
null
ACTIVE
2.69
2.69
96127-6
Evaluation note
Find
Pt
{Setting}
Doc
General medicine
DOC.ONTOLOGY
2
General medicine Evaluation note
General medicine Eval note
null
ACTIVE
2.69
2.69
96128-4
Evaluation note
Find
Pt
{Setting}
Doc
Colon and rectal surgery
DOC.ONTOLOGY
2
Colon and rectal surgery Evaluation note
Col+rec surg Eval note
null
ACTIVE
2.69
2.69
96129-2
Evaluation note
Find
Pt
{Setting}
Doc
Neurological surgery
DOC.ONTOLOGY
2
Neurological surgery Evaluation note
Neuro surgery Eval note
null
ACTIVE
2.69
2.69
961-3
C super little x Ab
PrThr
Pt
Ser/Plas^BPU
Ord
null
BLDBK
1
C sup(x) Ab [Presence] in Serum or Plasma from Blood product unit
C sup(x) Ab SerPl BPU Ql
null
ACTIVE
1.0
2.7
96130-0
Evaluation note
Find
Pt
{Setting}
Doc
Surgical oncology
DOC.ONTOLOGY
2
Surgical oncology Evaluation note
Surg Onc Eval note
null
ACTIVE
2.69
2.69
9613-1
Cortisol^2H post 250 ug corticotropin IM
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --2 hours post 250 ug corticotropin IM
Cortis 2h p 250 ug ACTH IM SerPl-mCnc
null
ACTIVE
1.0i
2.7
96131-8
Evaluation note
Find
Pt
{Setting}
Doc
Oral and maxillofacial surgery
DOC.ONTOLOGY
2
Oral and Maxillofacial Surgery Evaluation note
OMS Eval note
null
ACTIVE
2.69
2.69
96132-6
Evaluation note
Find
Pt
{Setting}
Doc
Cardiac surgery
DOC.ONTOLOGY
2
Cardiac surgery Evaluation note
Cardiac surgery Eval note
null
ACTIVE
2.69
2.69
96133-4
Evaluation note
Find
Pt
{Setting}
Doc
Pharmacology
DOC.ONTOLOGY
2
Pharmacology Evaluation note
Pharmacology Eval note
null
ACTIVE
2.69
2.69
96134-2
Evaluation note
Find
Pt
{Setting}
Doc
Occupational therapy
DOC.ONTOLOGY
2
Occupational therapy Evaluation note
OT Eval note
null
ACTIVE
2.69
2.69
96135-9
Evaluation note
Find
Pt
{Setting}
Doc
Nutrition and dietetics
DOC.ONTOLOGY
2
Nutrition and dietetics Evaluation note
Nutr+diet Eval note
null
ACTIVE
2.69
2.69
96136-7
Evaluation note
Find
Pt
{Setting}
Doc
Palliative care
DOC.ONTOLOGY
2
Palliative care Evaluation note
Palliative care Eval note
null
ACTIVE
2.69
2.69
96137-5
Evaluation note
Find
Pt
{Setting}
Doc
Oncology
DOC.ONTOLOGY
2
Oncology Evaluation note
Oncology Eval note
null
ACTIVE
2.69
2.69
96138-3
Evaluation note
Find
Pt
{Setting}
Doc
Obstetrics
DOC.ONTOLOGY
2
Obstetrics Evaluation note
OB Eval note
null
ACTIVE
2.69
2.69
96139-1
Evaluation note
Find
Pt
{Setting}
Doc
Neurology
DOC.ONTOLOGY
2
Neurology Evaluation note
Neurology Eval note
null
ACTIVE
2.69
2.69
96140-9
Evaluation note
Find
Pt
{Setting}
Doc
Nephrology
DOC.ONTOLOGY
2
Nephrology Evaluation note
Nephrology Eval note
null
ACTIVE
2.69
2.69
96141-7
Evaluation note
Find
Pt
{Setting}
Doc
Neonatal perinatal medicine
DOC.ONTOLOGY
2
Neonatal perinatal medicine Evaluation note
Neo peri med Eval note
null
ACTIVE
2.69
2.69
96142-5
Evaluation note
Find
Pt
{Setting}
Doc
Mental health
DOC.ONTOLOGY
2
Mental health Evaluation note
Mental health Eval note
null
ACTIVE
2.69
2.69
96143-3
Evaluation note
Find
Pt
{Setting}
Doc
Gynecology
DOC.ONTOLOGY
2
Gynecology Evaluation note
Gynecology Eval note
null
ACTIVE
2.69
2.69
96144-1
Evaluation note
Find
Pt
{Setting}
Doc
Geriatric medicine
DOC.ONTOLOGY
2
Geriatric medicine Evaluation note
Geri med Eval note
null
ACTIVE
2.69
2.69
96145-8
Evaluation note
Find
Pt
{Setting}
Doc
Emergency medicine
DOC.ONTOLOGY
2
Emergency medicine Evaluation note
Emergency med Eval note
null
ACTIVE
2.69
2.69
96146-6
Evaluation note
Find
Pt
{Setting}
Doc
Critical Care Medicine
DOC.ONTOLOGY
2
Critical care medicine Evaluation note
CCM Eval note
null
ACTIVE
2.69
2.69
96147-4
Evaluation note
Find
Pt
{Setting}
Doc
Vascular surgery
DOC.ONTOLOGY
2
Vascular surgery Evaluation note
Vascular surgery Eval note
null
ACTIVE
2.69
2.69
96148-2
Evaluation note
Find
Pt
{Setting}
Doc
Transplant surgery
DOC.ONTOLOGY
2
Transplant surgery Evaluation note
Transpl surg Eval note
null
ACTIVE
2.69
2.73
9614-9
Cortisol^45M post 250 ug corticotropin IM
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM
Cortis 45M p 250 ug ACTH IM SerPl-mCnc
null
ACTIVE
1.0i
2.7
96149-0
Evaluation note
Find
Pt
{Setting}
Doc
Thoracic and cardiac surgery
DOC.ONTOLOGY
2
Cardiothoracic surgery Evaluation note
Cardiothor surg Eval note
null
ACTIVE
2.69
2.69
96150-8
Evaluation note
Find
Pt
{Setting}
Doc
Plastic surgery
DOC.ONTOLOGY
2
Plastic surgery Evaluation note
Plastic surgery Eval note
null
ACTIVE
2.69
2.69
96151-6
Evaluation note
Find
Pt
{Setting}
Doc
Pediatric surgery
DOC.ONTOLOGY
2
Pediatric surgery Evaluation note
Peds surgery Eval note
null
ACTIVE
2.69
2.69
96152-4
Evaluation note
Find
Pt
{Setting}
Doc
Orthopaedic surgery
DOC.ONTOLOGY
2
Orthopaedic surgery Evaluation note
Orthopaedic surgery Eval note
null
ACTIVE
2.69
2.69
96153-2
Evaluation note
Find
Pt
{Setting}
Doc
Gastroenterology
DOC.ONTOLOGY
2
Gastroenterology Evaluation note
Gastroenterology Eval note
null
ACTIVE
2.69
2.69
96154-0
Evaluation note
Find
Pt
{Setting}
Doc
Pulmonary disease
DOC.ONTOLOGY
2
Pulmonary Evaluation note
Pulmonary disease Eval note
null
ACTIVE
2.69
2.69
96155-7
Evaluation note
Find
Pt
{Setting}
Doc
Wound care management
DOC.ONTOLOGY
2
Wound care management Evaluation note
Wound care management Eval note
null
ACTIVE
2.69
2.69
9615-6
Cortisol^1.5H post 250 ug corticotropin IM
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 250 ug corticotropin IM
Cortis 1.5h p 250 ug ACTH IM SerPl-mCnc
null
ACTIVE
1.0i
2.73
96156-5
Evaluation note
Find
Pt
{Setting}
Doc
Trauma
DOC.ONTOLOGY
2
Trauma Evaluation note
Trauma Eval note
null
ACTIVE
2.69
2.69
96157-3
Evaluation note
Find
Pt
{Setting}
Doc
Sports medicine
DOC.ONTOLOGY
2
Sports medicine Evaluation note
Sports medicine Eval note
null
ACTIVE
2.69
2.69
96158-1
Evaluation note
Find
Pt
{Setting}
Doc
Urology
DOC.ONTOLOGY
2
Urology Evaluation note
Urology Eval note
null
ACTIVE
2.69
2.69
96159-9
Evaluation note
Find
Pt
{Setting}
Doc
Otolaryngology
DOC.ONTOLOGY
2
Otolaryngology Evaluation note
Otolaryngology Eval note
null
ACTIVE
2.69
2.69
96160-7
Evaluation note
Find
Pt
{Setting}
Doc
Endocrinology
DOC.ONTOLOGY
2
Endocrinology Evaluation note
Endocrinology Eval note
null
ACTIVE
2.69
2.69
96161-5
Evaluation note
Find
Pt
{Setting}
Doc
Infectious disease
DOC.ONTOLOGY
2
Infectious disease Evaluation note
Infectious disease Eval note
null
ACTIVE
2.69
2.69
96162-3
Evaluation note
Find
Pt
{Setting}
Doc
Nurse practitioner
DOC.ONTOLOGY
2
Nurse practitioner Evaluation note
Nurse pract Eval note
null
ACTIVE
2.69
2.69
96163-1
Evaluation note
Find
Pt
{Setting}
Doc
Nurse
DOC.ONTOLOGY
2
Nurse Evaluation note
Nurse Eval note
null
ACTIVE
2.69
2.69
9616-4
17-Hydroxyprogesterone
MRat
24H
Urine
Qn
null
CHEM
1
17-Hydroxyprogesterone [Mass/time] in 24 hour Urine
17OHP 24h Ur-mRate
null
ACTIVE
1.0i
2.73
96164-9
Evaluation note
Find
Pt
{Setting}
Doc
Speech-language pathology
DOC.ONTOLOGY
2
Speech-language pathology Evaluation note
Speech-lang path Eval note
null
ACTIVE
2.69
2.69
96165-6
Evaluation note
Find
Pt
{Setting}
Doc
Respiratory therapy
DOC.ONTOLOGY
2
Respiratory therapy Evaluation note
Resp therapy Eval note
null
ACTIVE
2.69
2.69
96166-4
Evaluation note
Find
Pt
{Setting}
Doc
Bariatric surgery
DOC.ONTOLOGY
2
Bariatric surgery Evaluation note
Bariatric surg Eval note
null
ACTIVE
2.69
2.69
96167-2
Evaluation note
Find
Pt
{Setting}
Doc
Cardiovascular disease+Pulmonary disease
DOC.ONTOLOGY
2
Cardiopulmonary Evaluation note
Cardio+Pulm disease Eval note
null
ACTIVE
2.69
2.69
96168-0
Evaluation note
Find
Pt
{Setting}
Doc
Child and adolescent psychology
DOC.ONTOLOGY
2
Child and adolescent psychology Evaluation note
Child Adolsnt Psych Eval note
null
ACTIVE
2.69
2.69
96169-8
Evaluation note
Find
Pt
{Setting}
Doc
Dermatology
DOC.ONTOLOGY
2
Dermatology Evaluation note
Dermatology Eval note
null
ACTIVE
2.69
2.69
96170-6
Evaluation note
Find
Pt
Telephone encounter
Doc
{Role}
DOC.ONTOLOGY
2
Telephone encounter Evaluation note
Phone Eval note
null
ACTIVE
2.69
2.69
96171-4
Evaluation note
Find
Pt
{Setting}
Doc
Heart failure
DOC.ONTOLOGY
2
Heart failure Evaluation note
Heart failure Eval note
null
ACTIVE
2.69
2.69
9617-2
Chylomicrons
MCnc
Pt
Plr fld
Qn
null
CHEM
1
Chylomicrons [Mass/volume] in Pleural fluid
Chylo Plr-mCnc
null
ACTIVE
1.0i
2.42
96172-2
Evaluation note
Find
Pt
{Setting}
Doc
Clinical genetics
DOC.ONTOLOGY
2
Clinical genetics Evaluation note
Clinical genetics Eval note
null
ACTIVE
2.69
2.69
96173-0
Evaluation note
Find
Pt
{Setting}
Doc
Clinical pathology
DOC.ONTOLOGY
2
Clinical pathology Evaluation note
Clin Path Eval note
null
ACTIVE
2.69
2.69
96174-8
Evaluation note
Find
Pt
{Setting}
Doc
Interventional radiology
DOC.ONTOLOGY
2
Interventional radiology Evaluation note
IR Eval note
null
ACTIVE
2.69
2.69
96175-5
Evaluation note
Find
Pt
{Setting}
Doc
Kinesiotherapy
DOC.ONTOLOGY
2
Kinesiotherapy Evaluation note
Kinesiotherapy Eval note
null
ACTIVE
2.69
2.69